| Type |
Details |
Score |
| Allele |
| Name: |
BCL2 like 11; gene trap OST459171, Lexicon Genetics |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 13; gene trap AB0239, Wellcome Trust Sanger Institute |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 13; gene trap XS0709, Wellcome Trust Sanger Institute |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 13; gene trap XT0458, Wellcome Trust Sanger Institute |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 1.1, Philippe Bouillet |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 2.1, Philippe Bouillet |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 3.1, Philippe Bouillet |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; targeted mutation 1, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; targeted mutation 1, Roger J Davis |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; targeted mutation 2.1, Roger J Davis |
| Allele Type: |
Targeted |
| Attribute String: |
Not Specified |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; targeted mutation 3.1, Roger J Davis |
| Allele Type: |
Targeted |
| Attribute String: |
Not Specified |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; gene trap K13, H Earl Ruley |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; gene trap HM17-2, H Earl Ruley |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; gene trap HJ39, H Earl Ruley |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; gene trap E64R, H Earl Ruley |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 14; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 12; gene trap EUCJ00108g02, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 interacting protein 5; targeted mutation 1, Velocigene |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; targeted mutation 4.1, Roger J Davis |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 12; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 12; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 12; targeted mutation 2e, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 14; targeted mutation 2e, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 12; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 14; targeted mutation 2a, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 4, Philippe Bouillet |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 5, Philippe Bouillet |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 2, Stanley J Korsmeyer |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 6.1, Philippe Bouillet |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 interacting protein 5; targeted mutation 1.1, Velocigene |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; endonuclease-mediated mutation 1, Richard A Flavell |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 14; targeted mutation 1.1, Philippe Bouillet |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 1, David E Bergstrom |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Humanized sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; endonuclease-mediated mutation 1, David E Bergstrom |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Humanized sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; endonuclease-mediated mutation 2, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 13; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 13; endonuclease-mediated mutation 2, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 14; endonuclease-mediated mutation 16, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 14; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; endonuclease-mediated mutation 2, GemPharmatech Co., Ltd |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 modifying factor; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 1.1, Klaus Rajewsky |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 1.2, Klaus Rajewsky |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; targeted mutation 1.1, Toshitada Takemori |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; endonuclease-mediated mutation 1, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 11; endonuclease-mediated mutation 1, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 13; endonuclease-mediated mutation 1, Nils-Goran Larsson |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 like 13; endonuclease-mediated mutation 1, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; endonuclease-mediated mutation 2, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Allele |
| Name: |
BCL2 binding component 3; endonuclease-mediated mutation 3, Cyagen Biosciences |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Bcl2l11/Bcl2l11 |
| Background: |
C57BL/6NTac-Bcl2l11/H |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Bcl2l12/Bcl2l12 |
| Background: |
C57BL/6N-Bcl2l12/Ucd |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Siggs OM |
| Year: |
2011 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C. |
| Volume: |
108 |
| Issue: |
19 |
| Pages: |
7890-5 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Edgar CE |
| Year: |
2010 |
| Journal: |
Cell Death Differ |
| Title: |
CAML regulates Bim-dependent thymocyte death. |
| Volume: |
17 |
| Issue: |
10 |
| Pages: |
1566-76 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yano T |
| Year: |
2006 |
| Journal: |
Mol Cell Biol |
| Title: |
The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. |
| Volume: |
26 |
| Issue: |
12 |
| Pages: |
4474-88 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Happo L |
| Year: |
2010 |
| Journal: |
Blood |
| Title: |
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. |
| Volume: |
116 |
| Issue: |
24 |
| Pages: |
5256-67 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Qiu W |
| Year: |
2011 |
| Journal: |
J Clin Invest |
| Title: |
PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. |
| Volume: |
121 |
| Issue: |
5 |
| Pages: |
1722-32 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Valente LJ |
| Year: |
2013 |
| Journal: |
Cell Rep |
| Title: |
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. |
| Volume: |
3 |
| Issue: |
5 |
| Pages: |
1339-45 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Michalak EM |
| Year: |
2009 |
| Journal: |
Cell Death Differ |
| Title: |
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. |
| Volume: |
16 |
| Issue: |
5 |
| Pages: |
684-96 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li Y |
| Year: |
2013 |
| Journal: |
Nat Commun |
| Title: |
The p53-PUMA axis suppresses iPSC generation. |
| Volume: |
4 |
|
| Pages: |
2174 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lindemann RK |
| Year: |
2007 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma. |
| Volume: |
104 |
| Issue: |
19 |
| Pages: |
8071-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Maor-Nof M |
| Year: |
2016 |
| Journal: |
Neuron |
| Title: |
Axonal Degeneration Is Regulated by a Transcriptional Program that Coordinates Expression of Pro- and Anti-degenerative Factors. |
| Volume: |
92 |
| Issue: |
5 |
| Pages: |
991-1006 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Golec DP |
| Year: |
2017 |
| Journal: |
J Exp Med |
| Title: |
Thymic progenitors of TCRαβ+ CD8αα intestinal intraepithelial lymphocytes require RasGRP1 for development. |
| Volume: |
214 |
| Issue: |
8 |
| Pages: |
2421-2435 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huntington ND |
| Year: |
2009 |
| Journal: |
Int Immunol |
| Title: |
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim sustains B lymphopoiesis in the absence of IL-7. |
| Volume: |
21 |
| Issue: |
6 |
| Pages: |
715-25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Perier C |
| Year: |
2007 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. |
| Volume: |
104 |
| Issue: |
19 |
| Pages: |
8161-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Manlove LS |
| Year: |
2015 |
| Journal: |
J Immunol |
| Title: |
Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells. |
| Volume: |
195 |
| Issue: |
8 |
| Pages: |
4028-37 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kiss I |
| Year: |
2006 |
| Journal: |
Eur J Immunol |
| Title: |
Adenosine A2A receptor-mediated cell death of mouse thymocytes involves adenylate cyclase and Bim and is negatively regulated by Nur77. |
| Volume: |
36 |
| Issue: |
6 |
| Pages: |
1559-71 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ness JM |
| Year: |
2006 |
| Journal: |
Brain Res |
| Title: |
Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. |
| Volume: |
1099 |
| Issue: |
1 |
| Pages: |
150-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu S |
| Year: |
2012 |
| Journal: |
Blood |
| Title: |
The RNase III enzyme Dicer is essential for germinal center B-cell formation. |
| Volume: |
119 |
| Issue: |
3 |
| Pages: |
767-76 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hu QN |
| Year: |
2017 |
| Journal: |
J Immunol |
| Title: |
Nur77 Regulates Nondeletional Mechanisms of Tolerance in T Cells. |
| Volume: |
199 |
| Issue: |
9 |
| Pages: |
3147-3157 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chang KC |
| Year: |
2007 |
| Journal: |
FASEB J |
| Title: |
Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. |
| Volume: |
21 |
| Issue: |
3 |
| Pages: |
708-19 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Harder JM |
| Year: |
2013 |
| Journal: |
Cell Death Differ |
| Title: |
Deficiency in Bim, Bid and Bbc3 (Puma) do not prevent axonal injury induced death. |
| Volume: |
20 |
| Issue: |
1 |
| Pages: |
182 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Harder JM |
| Year: |
2011 |
| Journal: |
Mol Neurodegener |
| Title: |
BBC3 (PUMA) regulates developmental apoptosis but not axonal injury induced death in the retina. |
| Volume: |
6 |
|
| Pages: |
50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Muthalagu N |
| Year: |
2014 |
| Journal: |
Cell Rep |
| Title: |
BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues. |
| Volume: |
8 |
| Issue: |
5 |
| Pages: |
1347-53 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hu K |
| Year: |
2019 |
| Journal: |
Neuroscience |
| Title: |
c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease. |
| Volume: |
399 |
|
| Pages: |
117-124 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sugimoto-Ishige A |
| Year: |
2020 |
| Journal: |
Int Immunol |
| Title: |
Bim establishes the B cell repertoire from early to late in the immune response. |
|
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chao JR |
| Year: |
2008 |
| Journal: |
Nature |
| Title: |
Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. |
| Volume: |
452 |
| Issue: |
7183 |
| Pages: |
98-102 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lalanne AI |
| Year: |
2010 |
| Journal: |
J Immunol |
| Title: |
CpG inhibits pro-B cell expansion through a cathepsin B-dependent mechanism. |
| Volume: |
184 |
| Issue: |
10 |
| Pages: |
5678-85 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mérino D |
| Year: |
2012 |
| Journal: |
Blood |
| Title: |
Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. |
| Volume: |
119 |
| Issue: |
24 |
| Pages: |
5807-16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Van Dyken SJ |
| Year: |
2007 |
| Journal: |
Mol Cell Biol |
| Title: |
Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis. |
| Volume: |
27 |
| Issue: |
3 |
| Pages: |
1096-111 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yee KS |
| Year: |
2009 |
| Journal: |
Cell Death Differ |
| Title: |
PUMA- and Bax-induced autophagy contributes to apoptosis. |
| Volume: |
16 |
| Issue: |
8 |
| Pages: |
1135-45 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
204
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
Mus caroli |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|